FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2998740982> ?p ?o ?g. }

• W2998740982 endingPage "288" @default.
• W2998740982 startingPage "283" @default.
• W2998740982 abstract "The European Organization for Research and Treatment of Cancer (EORTC) QLQ-BR23 was one of the first disease-specific questionnaires developed in 1996 to assess quality of life (QoL) in patients with breast cancer (BC). However, since 1996 major changes in BC treatment have occurred, requiring an update of the EORTC BC module. This study presents the results of the phase I-III update of the QLQ-BR23 questionnaire.The update of the EORTC QLQ-BR23 module followed standard EORTC guidelines. A systematic literature review revealed 83 potential relevant QoL issues during phases I and II. After shortening the issues list and following interviews with patients and health care providers, 15 relevant issues were transformed into 27 items. The preliminary module was pretested in an international, multicentre phase III study to identify and solve potential problems with wording comprehensibility and acceptability of the items. Descriptive statistics are provided. Analyses were qualitative and quantitative. We provide a psychometric structure of the items.The phase I and II results indicated the need to supplement the original QLQ-BR23 with additional items related to newer therapeutic options. The phase III study recruited a total of 250 patients (from 12 countries). The final updated phase III module contains a total of 45 items: 23 items from the QLQ-BR23 and 22 new items. The new items contain two multi-item scales: a target symptom scale and a satisfaction scale. The target symptom scale can be divided into three subscales: endocrine therapy, endocrine sexual and skin/mucosa scale.Our work has led to the development of a new EORTC QLQ-BR45 module that provides a more accurate and comprehensive assessment of the impact of new and scalable treatments on patients' QoL. The final version of the EORTC QLQ-BR45 is currently available for use in clinical practice. The final phase IV study is underway to confirm psychometric properties of the module." @default.
• W2998740982 created "2020-01-23" @default.
• W2998740982 creator A5005973748 @default.
• W2998740982 creator A5006112140 @default.
• W2998740982 creator A5007286394 @default.
• W2998740982 creator A5013554203 @default.
• W2998740982 creator A5016335263 @default.
• W2998740982 creator A5020997210 @default.
• W2998740982 creator A5021008563 @default.
• W2998740982 creator A5022097827 @default.
• W2998740982 creator A5022499341 @default.
• W2998740982 creator A5022745626 @default.
• W2998740982 creator A5022943921 @default.
• W2998740982 creator A5025554206 @default.
• W2998740982 creator A5026335955 @default.
• W2998740982 creator A5029183739 @default.
• W2998740982 creator A5031777632 @default.
• W2998740982 creator A5037530630 @default.
• W2998740982 creator A5040155315 @default.
• W2998740982 creator A5041065594 @default.
• W2998740982 creator A5042183900 @default.
• W2998740982 creator A5042234098 @default.
• W2998740982 creator A5043068937 @default.
• W2998740982 creator A5044216161 @default.
• W2998740982 creator A5049211488 @default.
• W2998740982 creator A5054728208 @default.
• W2998740982 creator A5058763790 @default.
• W2998740982 creator A5072723216 @default.
• W2998740982 creator A5074453877 @default.
• W2998740982 creator A5074874301 @default.
• W2998740982 creator A5075151599 @default.
• W2998740982 creator A5083358710 @default.
• W2998740982 creator A5087014063 @default.
• W2998740982 creator A5087782965 @default.
• W2998740982 creator A5087788273 @default.
• W2998740982 creator A5088353994 @default.
• W2998740982 creator A5090166802 @default.
• W2998740982 creator A5090970249 @default.
• W2998740982 date "2020-02-01" @default.
• W2998740982 modified "2023-10-10" @default.
• W2998740982 title "An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45" @default.
• W2998740982 cites W1848007259 @default.
• W2998740982 cites W1857624176 @default.
• W2998740982 cites W1967612488 @default.
• W2998740982 cites W2003321779 @default.
• W2998740982 cites W2088875220 @default.
• W2998740982 cites W2115606499 @default.
• W2998740982 cites W2125620887 @default.
• W2998740982 cites W2155445734 @default.
• W2998740982 cites W2293838703 @default.
• W2998740982 cites W2313479654 @default.
• W2998740982 cites W2765900544 @default.
• W2998740982 cites W2767889231 @default.
• W2998740982 doi "https://doi.org/10.1016/j.annonc.2019.10.027" @default.
• W2998740982 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31959345" @default.
• W2998740982 hasPublicationYear "2020" @default.
• W2998740982 type Work @default.
• W2998740982 sameAs 2998740982 @default.
• W2998740982 citedByCount "40" @default.
• W2998740982 countsByYear W29987409822020 @default.
• W2998740982 countsByYear W29987409822021 @default.
• W2998740982 countsByYear W29987409822022 @default.
• W2998740982 countsByYear W29987409822023 @default.
• W2998740982 crossrefType "journal-article" @default.
• W2998740982 hasAuthorship W2998740982A5005973748 @default.
• W2998740982 hasAuthorship W2998740982A5006112140 @default.
• W2998740982 hasAuthorship W2998740982A5007286394 @default.
• W2998740982 hasAuthorship W2998740982A5013554203 @default.
• W2998740982 hasAuthorship W2998740982A5016335263 @default.
• W2998740982 hasAuthorship W2998740982A5020997210 @default.
• W2998740982 hasAuthorship W2998740982A5021008563 @default.
• W2998740982 hasAuthorship W2998740982A5022097827 @default.
• W2998740982 hasAuthorship W2998740982A5022499341 @default.
• W2998740982 hasAuthorship W2998740982A5022745626 @default.
• W2998740982 hasAuthorship W2998740982A5022943921 @default.
• W2998740982 hasAuthorship W2998740982A5025554206 @default.
• W2998740982 hasAuthorship W2998740982A5026335955 @default.
• W2998740982 hasAuthorship W2998740982A5029183739 @default.
• W2998740982 hasAuthorship W2998740982A5031777632 @default.
• W2998740982 hasAuthorship W2998740982A5037530630 @default.
• W2998740982 hasAuthorship W2998740982A5040155315 @default.
• W2998740982 hasAuthorship W2998740982A5041065594 @default.
• W2998740982 hasAuthorship W2998740982A5042183900 @default.
• W2998740982 hasAuthorship W2998740982A5042234098 @default.
• W2998740982 hasAuthorship W2998740982A5043068937 @default.
• W2998740982 hasAuthorship W2998740982A5044216161 @default.
• W2998740982 hasAuthorship W2998740982A5049211488 @default.
• W2998740982 hasAuthorship W2998740982A5054728208 @default.
• W2998740982 hasAuthorship W2998740982A5058763790 @default.
• W2998740982 hasAuthorship W2998740982A5072723216 @default.
• W2998740982 hasAuthorship W2998740982A5074453877 @default.
• W2998740982 hasAuthorship W2998740982A5074874301 @default.
• W2998740982 hasAuthorship W2998740982A5075151599 @default.
• W2998740982 hasAuthorship W2998740982A5083358710 @default.
• W2998740982 hasAuthorship W2998740982A5087014063 @default.
• W2998740982 hasAuthorship W2998740982A5087782965 @default.
• W2998740982 hasAuthorship W2998740982A5087788273 @default.
• W2998740982 hasAuthorship W2998740982A5088353994 @default.

• next